학술논문
Burosumab resulted in better clinical outcomes than continuation with conventional therapy in younger and older children with X-linked hypophosphatemia
Document Type
ConferencePaper
Author
Source
JOURNAL OF BONE AND MINERAL RESEARCH. 34:13-13
Subject
Language
English
English
English
ISSN
0884-0431